Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,909,817
+$614,072 QoQ
Shares Held
2,426
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.94%
of 13F equity value
Holder Rank
#2,158
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $9,117,824 across 12 Drug Manufacturers - General names. LLY ranks #1 (31.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,426 | $2,909,817 | |
| 2 | JNJ |
Johnson & Johnson
|
9,783 | $2,484,588 | |
| 3 | ABBV |
AbbVie Inc.
|
8,090 | $2,035,767 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,717 | $863,134 | |
| 5 | AMGN |
Amgen Inc
|
1,126 | $407,747 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,222 | $280,727 | |
| 7 | PFE |
Pfizer Inc
|
2,704 | $65,112 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
648 | $37,337 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,909,817 | 2,426 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,295,745 | 2,496 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,931,727 | 2,728 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,076,123 | 2,721 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,135,132 | 2,739 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,193,616 | 2,656 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,007,972 | 2,601 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,484,175 | 2,804 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,524,199 | 2,788 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,202,404 | 2,831 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,678,226 | 2,879 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,615,149 | 3,007 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $1,554,199 | 3,314 | Shares | Sole | 2023-12-18 | |
| 2023-03-31 | $1,198,535 | 3,490 | Shares | Sole | 2023-12-18 | |
| 2022-12-31 | $1,297,268 | 3,546 | Shares | Sole | 2023-12-18 | |
| 2022-09-30 | $1,205,125 | 3,727 | Shares | Sole | 2023-12-19 | |
| 2022-06-30 | $1,300,486 | 4,011 | Shares | Sole | 2023-12-19 | |
| 2022-03-31 | $1,290,669 | 4,507 | Shares | Sole | 2023-12-19 | |
| 2021-12-31 | $1,212,329 | 4,389 | Shares | Sole | 2023-12-20 | |
| 2021-09-30 | $1,032,562 | 4,469 | Shares | Sole | 2023-12-20 | |
| 2021-06-30 | $868,962 | 3,786 | Shares | Sole | 2023-12-20 | |
| 2021-03-31 | $778,852 | 4,169 | Shares | Sole | 2023-12-20 | |
| 2020-12-31 | $679,074 | 4,022 | Shares | Sole | 2023-12-20 | |
| 2020-09-30 | $584,382 | 3,948 | Shares | Sole | 2023-12-20 | |
| 2020-06-30 | $652,779 | 3,976 | Shares | Sole | 2023-12-20 | |
| 2020-03-31 | $525,610 | 3,789 | Shares | Sole | 2023-12-21 | |
| No filing history on record for this holder in this stock. | ||||||